![Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of RECTIV® (nitroglycerin) ointment, 0.4%, with 180 days Competitive Generic Therapy (CGT) exclusivity – Company Announcement - FT.com Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of RECTIV® (nitroglycerin) ointment, 0.4%, with 180 days Competitive Generic Therapy (CGT) exclusivity – Company Announcement - FT.com](https://mms.businesswire.com/media/20240222076554/en/2041963/4/Nitroglycerin_Ointment.jpg)
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of RECTIV® (nitroglycerin) ointment, 0.4%, with 180 days Competitive Generic Therapy (CGT) exclusivity – Company Announcement - FT.com
![About RECTIV (nitroglycerin) Ointment, a treatment for moderate to severe pain of chronic anal fissure About RECTIV (nitroglycerin) Ointment, a treatment for moderate to severe pain of chronic anal fissure](https://www.rectiv.com/Assets/Images/product.jpg)
About RECTIV (nitroglycerin) Ointment, a treatment for moderate to severe pain of chronic anal fissure
![These highlights do not include all the information needed to use RECTIV®( nitroglycerin) Ointment 0.4% safely and effectively. See full prescribing information for RECTIV. RECTIV (nitroglycerin) Ointment 0.4%, for intra-anal useInitial U.S. Approval: These highlights do not include all the information needed to use RECTIV®( nitroglycerin) Ointment 0.4% safely and effectively. See full prescribing information for RECTIV. RECTIV (nitroglycerin) Ointment 0.4%, for intra-anal useInitial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=rectiv-4.jpg&id=709846)
These highlights do not include all the information needed to use RECTIV®( nitroglycerin) Ointment 0.4% safely and effectively. See full prescribing information for RECTIV. RECTIV (nitroglycerin) Ointment 0.4%, for intra-anal useInitial U.S. Approval:
![These highlights do not include all the information needed to use RECTIV®( nitroglycerin) Ointment 0.4% safely and effectively. See full prescribing information for RECTIV. RECTIV (nitroglycerin) Ointment 0.4%, for intra-anal useInitial U.S. Approval: These highlights do not include all the information needed to use RECTIV®( nitroglycerin) Ointment 0.4% safely and effectively. See full prescribing information for RECTIV. RECTIV (nitroglycerin) Ointment 0.4%, for intra-anal useInitial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=rectiv-1.jpg&id=709846)
These highlights do not include all the information needed to use RECTIV®( nitroglycerin) Ointment 0.4% safely and effectively. See full prescribing information for RECTIV. RECTIV (nitroglycerin) Ointment 0.4%, for intra-anal useInitial U.S. Approval:
![Nitroglycerin 0.4% ointment vs placebo in the treatment of pain resulting from chronic anal fissure: a randomized, double-blind, placebo-controlled study | BMC Gastroenterology | Full Text Nitroglycerin 0.4% ointment vs placebo in the treatment of pain resulting from chronic anal fissure: a randomized, double-blind, placebo-controlled study | BMC Gastroenterology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-230X-13-106/MediaObjects/12876_2012_Article_970_Fig1_HTML.jpg)
Nitroglycerin 0.4% ointment vs placebo in the treatment of pain resulting from chronic anal fissure: a randomized, double-blind, placebo-controlled study | BMC Gastroenterology | Full Text
![PDF) Nitroglycerin 0.4% ointment vs placebo in the treatment of pain resulting from chronic anal fissure: A randomized, double-blind, placebo-controlled study PDF) Nitroglycerin 0.4% ointment vs placebo in the treatment of pain resulting from chronic anal fissure: A randomized, double-blind, placebo-controlled study](https://i1.rgstatic.net/publication/244479381_Nitroglycerin_04_ointment_vs_placebo_in_the_treatment_of_pain_resulting_from_chronic_anal_fissure_A_randomized_double-blind_placebo-controlled_study/links/0deec53974eeac969d000000/largepreview.png)
PDF) Nitroglycerin 0.4% ointment vs placebo in the treatment of pain resulting from chronic anal fissure: A randomized, double-blind, placebo-controlled study
![These highlights do not include all the information needed to use RECTIV®( nitroglycerin) Ointment 0.4% safely and effectively. See full prescribing information for RECTIV. RECTIV (nitroglycerin) Ointment 0.4%, for intra-anal useInitial U.S. Approval: These highlights do not include all the information needed to use RECTIV®( nitroglycerin) Ointment 0.4% safely and effectively. See full prescribing information for RECTIV. RECTIV (nitroglycerin) Ointment 0.4%, for intra-anal useInitial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=rectiv-3.jpg&id=709846)
These highlights do not include all the information needed to use RECTIV®( nitroglycerin) Ointment 0.4% safely and effectively. See full prescribing information for RECTIV. RECTIV (nitroglycerin) Ointment 0.4%, for intra-anal useInitial U.S. Approval:
![Nitrostat Ointment 30gm, schedule: H, , NITROGLYCERIN, 0.2%W/W, , MARUTI PHARMA, OINTMENT, , Angina - NepalMedishop Nitrostat Ointment 30gm, schedule: H, , NITROGLYCERIN, 0.2%W/W, , MARUTI PHARMA, OINTMENT, , Angina - NepalMedishop](https://nepmed-uat.s3.ap-southeast-1.amazonaws.com/products/600x600/90361/nitrostat_ointment_30gm_1.jpg)